Revvity to Present at Upcoming Investor Conferences
Citi's 2024 Unplugged MedTech and Life Sciences Access Day -
KeyBanc 4th Annual
9:00 a.m. ET– Yves Dubaquie, senior vice president, diagnostics and
Attendees will receive an update on the Company and its strategic priorities.
Live audio webcasts will be available on the Events section of the Company’s website. Replays of the presentations will be posted on the Revvity Investor Relations website after the events and will be available for at least 30 days.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With 2023 revenue of more than
Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240221061578/en/
Investor Relations:
steve.willoughby@revvity.com
Media Relations:
(781) 663-5719
chet.murray@revvity.com
Source: Revvity